GERM | ETFMG Treatments, Testing and Advancements ETF Overview

(Stock Exchange: AMEX)

Day's Range	19.16 - 19.28
52 Week Range	16.32 - 20.20
Beta	0.88
Implied Volatility	48.98%
IV Rank	45.86%
Day's Volume	4,828
Average Volume	1,300
Shares Outstanding	500,398
Inception Date	2020-06-18

Assets	9,410,750
Asset Class	Equity
Expense Ratio	0.68
P/E Ratio	7.45
EPS	2.57
Dividend Yield	1.84%
Dividend Per Share	0.35
Dividend ExDate	N/A
Dividend PayDate	N/A

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

*Chart delayed

Watching at GERM technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on GERM Technicals page.